[Asia Economy Reporter Hyunseok Yoo] Jin System announced on the 28th that it participated in the ‘2021 Dubai International Medical Device Exhibition (MEDLAB Middle East 2021)’ and showcased molecular diagnostic equipment and diagnostic kits.


Jin System participated in this exhibition with the purpose of seeking partnerships with global diagnostic content companies by exhibiting molecular diagnostic equipment and diagnostic kits based on the company’s core technologies: biochip-based rapid PCR technology and High Multiplex technology.


The 2021 Dubai Diagnostic and Medical Device Exhibition (MEDLAB Middle East 2021) was held for four days from the 21st to the 24th at the Dubai International Convention Centre. Various in vitro diagnostic products, including COVID-19 diagnostic products, were launched.


During the exhibition, Jin System created various business promotion opportunities, conducting approximately 100 purchase consultations related to molecular diagnostic equipment and diagnostic kits. In particular, the product portfolio suitable for small and medium-sized medical institutions and testing centers attracted the attention of visitors. Jin System self-assessed that through this exhibition, it will be possible to expand its achievements in the Middle East and Africa regions, where it has already successfully entered and achieved sales results.



Seo Yujin, CEO of Jin System, stated, “There was high interest and positive response on-site for Jin System, which has a comprehensive portfolio of molecular diagnostics including molecular diagnostic equipment, respiratory 5-type simultaneous diagnostic kits, and tuberculosis diagnostic kits. We hope that this opportunity, where our proprietary technology enabling rapid and accurate on-site diagnosis was highlighted, will lead to the expansion of global partnerships.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing